Formulation of a 3D printable hydrogel for the development of solid rectal drug delivery system

  1. Muñoz Perez E 3
  2. Manuela Igartua Olaechea 123
  3. Edorta Santos Vizcaíno 123
  4. Rosa María Hernández Martín 123
  1. 1 Bioaraba, NanoBioCel Research Group, Vitoria-Gasteiz, Spain
  2. 2 Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN)
  3. 3 NanoBioCel Group, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain.
Revista:
RESCIFAR Revista Española de Ciencias Farmacéuticas

ISSN: 2660-6356

Año de publicación: 2021

Título del ejemplar: XV CONGRESO DE LA SOCIEDAD ESPAÑOLA DE FARMACIA INDUSTRIA Y GALÉNICA

Volumen: 2

Número: 2

Páginas: 213-215

Tipo: Artículo

Otras publicaciones en: RESCIFAR Revista Española de Ciencias Farmacéuticas

Resumen

Since the FDA approved the use of the first formulation manufactured by 3D printing in 2015, the application of this technology to obtain new and improved pharmaceutical formulations is on the rise. Nowadays, 3D printing is considered a reproducible, reliable, fast and easily manageable technique that allows a precise design of formulations. Thus, the high precision in manufacturing allows greater control over the characteristics and behaviour of each printed design. 3D printing of solid rectal formulations is particularly interesting as it offers an alternative for their production, obtaining results of greater morphological complexity and modified release profiles. Thus, the design of new printable materials suitable for their application in this field has become necessary. The aim of this project was to design and to evaluate a hydrogel composed by alginate and Laponite XLG as a bioink suitable for the obtainment of 3D-printed rectal formulations.